ExeVir Bio BV announces its participation in the 8th Annual Healthtech Investment Forum organized by SACHS Associates taking place virtually 5th-6th October 2021.

Torsten Mummenbrauer, Chief Executive Officer of ExeVir will be speaking on a panel discussion titled “Advances in Covid Therapeutics” taking place at 11.00 CET on Wednesday 6th October 2021 and chaired by Max Herrmann, Managing Director, Stifel Financial Corp.

Read more…

By Optimum

For more information about Optimum Strategic Communications, please get in touch

We'd love to hear from you...